High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
高通量诱变技术可鉴定控制 CD19 剪接和 CAR-19 疗法耐药性的突变和 RNA 结合蛋白。
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-31818-y
Mariela Cortés-López #,Laura Schulz #,Mihaela Enculescu #,Claudia Paret,Bea Spiekermann,Mathieu Quesnel-Vallières,Manuel Torres-Diz,Sebastian Unic,Anke Busch,Anna Orekhova,Monika Kuban,Mikhail Mesitov,Miriam M Mulorz,Rawan Shraim,Fridolin Kielisch,Jörg Faber,Yoseph Barash,Andrei Thomas-Tikhonenko,Kathi Zarnack,Stefan Legewie,Julian König